Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuan Tian

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Toxicology and Applied Pharmacology|September 30, 2022
Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicology and Applied Pharmacology 360 (2018) 1-8]Yan-Rong Liu, Bo Sun, Guo-Hong Zhu, et al.
Toxicology and Applied Pharmacology|September 22, 2018
Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transitionYan-Rong Liu, Bo Sun, Guo-Hong Zhu, et al.
Toxicology and Applied Pharmacology|December 10, 2021
Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicol Appl Pharmacol 360 (2018) 1-8]Yan-Rong Liu, Bo Sun, Guo-Hong Zhu, et al.
Japanese Journal of Radiology|July 4, 2026
Atherosclerotic middle cerebral artery stenosis: adjacent arterial geometry, hemodynamics and plaque featuresYu Liu, Shuang Li, Yue Gu, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 1, 2025
Enlarged Translesional Pressure Gradient Drives Recruitment of Leptomeningeal Collaterals in Medically Treated Patients with Symptomatic Middle Cerebral Artery StenosisYuying Liu, Xuan Tian, Jill Abrigo, et al.
Stroke and Vascular Neurology|September 14, 2022
Risk stratification in symptomatic intracranial atherosclerotic disease with conventional vascular risk factors and cerebral haemodynamicsXuan Tian, Hui Fang, Linfang Lan, et al.
Translational Stroke Research|March 10, 2023
Cerebral Hemodynamics Underlying Artery-to-Artery Embolism in Symptomatic Intracranial Atherosclerotic DiseaseXueyan Feng, Hui Fang, Bonaventure Y M Ip, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 28, 2023
Cerebral hemodynamics and stroke risks in symptomatic intracranial atherosclerotic stenosis with internal versus cortical borderzone infarcts: A computational fluid dynamics studyShuang Li, Xuan Tian, Bonaventure Ip, et al.
European Stroke Journal|October 6, 2023
Hemodynamic significance of intracranial atherosclerotic disease and ipsilateral imaging markers of cerebral small vessel diseaseLina Zheng, Xuan Tian, Jill Abrigo, et al.
CNS Neuroscience & Therapeutics|January 12, 2026
Wall Shear Stress Distribution in Intracranial Atherosclerotic Disease and Associations With Vessel and Plaque MorphologyLinfang Lan, Shuang Li, Haipeng Liu, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Toxicology and Applied Pharmacology|September 30, 2022
Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicology and Applied Pharmacology 360 (2018) 1-8]Yan-Rong Liu, Bo Sun, Guo-Hong Zhu, et al.
Toxicology and Applied Pharmacology|September 22, 2018
Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transitionYan-Rong Liu, Bo Sun, Guo-Hong Zhu, et al.
Toxicology and Applied Pharmacology|December 10, 2021
Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicol Appl Pharmacol 360 (2018) 1-8]Yan-Rong Liu, Bo Sun, Guo-Hong Zhu, et al.
Japanese Journal of Radiology|July 4, 2026
Atherosclerotic middle cerebral artery stenosis: adjacent arterial geometry, hemodynamics and plaque featuresYu Liu, Shuang Li, Yue Gu, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 1, 2025
Enlarged Translesional Pressure Gradient Drives Recruitment of Leptomeningeal Collaterals in Medically Treated Patients with Symptomatic Middle Cerebral Artery StenosisYuying Liu, Xuan Tian, Jill Abrigo, et al.
Stroke and Vascular Neurology|September 14, 2022
Risk stratification in symptomatic intracranial atherosclerotic disease with conventional vascular risk factors and cerebral haemodynamicsXuan Tian, Hui Fang, Linfang Lan, et al.
Translational Stroke Research|March 10, 2023
Cerebral Hemodynamics Underlying Artery-to-Artery Embolism in Symptomatic Intracranial Atherosclerotic DiseaseXueyan Feng, Hui Fang, Bonaventure Y M Ip, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 28, 2023
Cerebral hemodynamics and stroke risks in symptomatic intracranial atherosclerotic stenosis with internal versus cortical borderzone infarcts: A computational fluid dynamics studyShuang Li, Xuan Tian, Bonaventure Ip, et al.
European Stroke Journal|October 6, 2023
Hemodynamic significance of intracranial atherosclerotic disease and ipsilateral imaging markers of cerebral small vessel diseaseLina Zheng, Xuan Tian, Jill Abrigo, et al.
CNS Neuroscience & Therapeutics|January 12, 2026
Wall Shear Stress Distribution in Intracranial Atherosclerotic Disease and Associations With Vessel and Plaque MorphologyLinfang Lan, Shuang Li, Haipeng Liu, et al.
Pageof 17